Café

© 2026 Longbridge｜Terms of Service Privacy Policy

TRAX

TRAX

48.1102.91%( +1.360 )

LongbridgeAI

First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.

benzinga_article

Jul 10, 2026 at 11:34 AM

First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

First Tracks Biotherapeutics

TRAX.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--